Released Feb 29, 2016, after the close
10-K filed Feb 29, 2016, 60 days after period end · 0001564590-16-013722
Q4 2015 · 10-K
Revenue$104.62M$104.62M +4.3% vs Q4 2014+3.4% vs Q3 2015
Net Income$3.37M$3.37M N/M vs Q4 2014N/M vs Q3 2015
EPS Diluted$0.18$0.18 N/M vs Q4 2014N/M vs Q3 2015
Gross Profit$83,211,000+5.6%
Operating Income$7,380,000+86.7%
Operating Cash Flowderived$17,071,000+12.3%
Free Cash Flowderived$10,854,000+28.4%
Margins · derived
Gross margin79.5%+0.9 pt vs Q4 2014
Operating margin7.1%+3.1 pt vs Q4 2014
Net margin3.2%+9.0 pt vs Q4 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $104.62M | $100.28M | $105.89M | $115.61M |
| Net Income | $3.37M | -$5.80M | -$10.41M | $22.95M |
| EPS Diluted | $0.18 | -$0.31 | -$0.58 | $1.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR